Stem cell homing and angiomyogenesis in transplanted hearts are enhanced by combined intramyocardial SDF-1α delivery and endogenous cytokine signaling

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 296, Issue 4, 2009, Pages

  Zhao, Tiemin ^a,b   Zhang, Dongsheng ^a   Millard, Ronald W ^a   Ashraf, Muhammad ^a   Wang, Yigang ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b Qinghai Red Cross Hospital   (China)

Author keywords

Cell migration; Heterotopic heart transplantation; Stem cells; Stromal cell derived factor 1a

Indexed keywords

BROXURIDINE; GREEN FLUORESCENT PROTEIN; KI 67 ANTIGEN; STROMAL CELL DERIVED FACTOR 1ALPHA;

ANGIOMYOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CIRCULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EXPERIMENTAL MODEL; FEMALE; GENE OVEREXPRESSION; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART TRANSPLANTATION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; ISCHEMIC HEART DISEASE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MUSCLE DEVELOPMENT; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; STEM CELL; TRANSGENIC RAT; Y CHROMOSOME;

ANIMALS; CELL MOVEMENT; CHEMOKINE CXCL12; COLLAGEN; CYTOKINES; DISEASE MODELS, ANIMAL; GREEN FLUORESCENT PROTEINS; HEART TRANSPLANTATION; MALE; MESENCHYMAL STEM CELLS; MUSCLE DEVELOPMENT; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 66149093343     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01134.2008     Document Type: Article

References (37)

1. Almsherqi ZA, McLachlan CS, Slocinska MB, Sluse FE, Navet R, Kocherginsky N, Kostetski I, Shi DY, Liu SL, Mossop P, Deng Y. Reduced cardiac output is associated with decreased mitochondrial efficiency in the non-ischemic ventricular wall of the acute myocardial- infarcted dog. Cell Res 16: 297-305, 2006.
2. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85: 221-228, 1999.
3. Asfour B, Hare JM, Kohl T, Baba HA, Kass DA, Chen K, Tjan TD, Hammel D, Weyand M, Hruban RH, Scheld HH, Byrne BJ. A simple new model of physiologically working heterotopic rat heart transplantation provides hemodynamic performance equivalent to that of an orthotopic heart. J Heart Lung Transplant 18: 927-936, 1999.
4. Ayach BB, Yoshimitsu M, Dawood F, Sun M, Arab S, Chen M, Higuchi K, Siatskas C, Lee P, Lim H, Zhang J, Cukerman E, Stanford WL, Medin JA, Liu PP. Stem cell factor receptor induces progenitor and natural killer cell-mediated cardiac survival and repair after myocardial infarction. Proc Natl Acad Sci USA 103:2304-2309, 2006.
5. Carr AN, Howard BW, Yang HT, Eby-Wilkens E, Loos P, Varbanov A, Qu A, DeMuth JP, Davis MG, Proia A, Terjung RL, Peters KG. Efficacy of systemic administration of SDF-1 in a model of vascular insufficiency: support for an endothelium-dependent mechanism. Cardiovasc Res 69: 925-935, 2006.
6. Chamberlain G, Fox J, Ashton B, Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immu- nological features, and potential for homing. Stem Cells 25: 2739-2749, 2007.
7. Herodin F, Bourin P, Mayol JF, Lataillade JJ, Drouet M. Short-term injection of antiapoptotic cytokine combinations soon after lethal gamma- irradiation promotes survival. Blood 101: 2609 -2616, 2003.
8. Hu X, Dai S, Wu WJ, Tan W, Zhu X, Mu J, Guo Y, Bolli R, Rokosh G. Stromal cell-derived factor-1 alpha confers protection against myocar- dial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis. Circulation 116: 654 - 663, 2007.
9. James N, Smith M. Treatment of heart failure in children. Curr Pediatr 15: 539 -548, 2005.
10. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, Asahara T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 97: 3422-3427, 2000.
11. Klein I, Hong C, Schreiber SS. Cardiac atrophy in the heterotopically transplanted rat heart: in vitro protein synthesis. J Mol Cell Cardiol 22: 461-468, 1990.
12. Klein I, Ojamaa K, Samarel AM, Welikson R, Hong C. Hemodynamiregulation of myosin heavy chain gene expression. Studies in the transplanted rat heart. J Clin Invest 89: 68-73, 1992.
13. Korecky B, Zak R, Schwartz K, Aschenbrenner V. Role of thyroid hormone in regulation of isomyosin composition, contractility, and size of heterotopically isotransplanted rat heart. Circ Res 60: 824-830, 1987.
14. Kortesidis A, Zannettino A, Isenmann S, Shi S, Lapidot T, Gronthos S. Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood 105: 3793-3801, 2005.
15. Kucia M, Dawn B, Hunt G, Guo Y, Wysoczynski M, Majka M, Ratajczak J, Rezzoug F, Ildstad ST, Bolli R, Ratajczak MZ. Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction. Circ Res 95: 1191-1199, 2004.
16. Lapidot T, Kollet O. The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2m(null) mice. Leukemia 16: 1992-2003, 2002.
17. Maruyama T, Swartz MT, McBride LR, Pennington DG. Working heart model of heterotopic heart-lung transplantation in rats. J Thorac Cardiovasc Surg 107: 210-215, 1994.
18. Massad MG. Current trends in heart transplantation. Cardiology 101: 79-92, 2004.
19. Miyahara Y, Nagaya N, Kataoka M, Yanagawa B, Tanaka K, Hao H, Ishino K, Ishida H, Shimizu T, Kangawa K, Sano S, Okano T, Kitamura S, Mori H. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 12: 459 -465, 2006.
20. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 57: 225-229, 1969.
21. Pasha Z, Wang Y, Sheikh R, Zhang D, Zhao T, Ashraf M. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res 77: 134-142, 2008.
22. Rubio PA, Guinn GA. Myocardial infarction following carotid endarter- ectomy. Cardiovasc Dis 2: 402-404, 1975.
23. Sakihama H, Masunaga T, Yamashita K, Hashimoto T, Inobe M, Todo S, Uede T. Stromal cell-derived factor-1 and CXCR4 interaction is critical for development of transplant arteriosclerosis. Circulation 110: 2924-2930, 2004.
24. Sasaki T, Fukazawa R, Ogawa S, Kanno S, Nitta T, Ochi M, Shimizu K. Stromal cell-derived factor-1alpha improves infarcted heart function through angiogenesis in mice. Pediatr Int 49: 966 -971, 2007.
25. Saxena A, Fish JE, White MD, Yu S, Smyth JW, Shaw RM, DiMaio JM, Srivastava D. Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction. Circulation 117: 2224 -2231, 2008.
26. Scholzen T, Gerdes J. The ki-67 protein: from the known and the unknown. J Cell Physiol 182: 311-322, 2000.
27. Schwartz Y, Kornowski R. Autologous stem cells for functional myo- cardial repair. Heart Fail Rev 8: 237-245, 2003.
28. Segers VF, Tokunou T, Higgins LJ, MacGillivray C, Gannon J, Lee RT. Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation 116: 16831692, 2007.
29. Seyfarth M, Sibbing D, Bauer I, Fröhlich G, Bott-Flügel L, Byrne R, Dirschinger J, Kastrati A, Schfimig A. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 52: 1584-1588, 2008.
30. Wang CH, Anderson N, Li SH, Szmitko PE, Cherng WJ, Fedak PW, Fazel S, Li RK, Yau TM, Weisel RD, Stanford WL, Verma S. Stem cell factor deficiency is vasculoprotective: unraveling a new therapeutic potential of imatinib mesylate. Circ Res 99: 617-625, 2006.
31. Wang Y, Ahmad N, Wang B, Ashraf M. Chronic preconditioning: a novel approach for cardiac protection. Am J Physiol Heart Circ Physiol 292: H2300-H2305, 2007.
32. Wang Y, Ahmad N, Wani MA, Ashraf M. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis. J Mol Cell Cardiol 37: 1041-1052, 2004.
33. Wang Y, Haider HK, Ahmad N, Xu M, Ge R, Ashraf M. Combining pharmacological mobilization with intramyocardial delivery of bone marrow cells over-expressing VEGF is more effective for cardiac repair. J Mol Cell Cardiol 40: 736-745, 2006.
34. Wang Y, Haider HK, Ahmad N, Zhang D, Ashraf M. Evidence for ischemia induced host-derived bone marrow cell mobilization into cardiac allografts. J Mol Cell Cardiol 41: 478-487, 2006.
35. Yokoyama H, Ohmi M, Murata S, Nakame T, Tabayashi K, Mohre H. Proposal of a working left heart model with a heterotopic transplantation technique in rats. J Heart Lung Transplant 14: 706-712, 1995.
36. Zeltsman D, Acker MA. Surgical management of heart failure: an overview. Annu Rev Med 53: 383-391, 2002.
37. Zemani F, Silvestre JS, Fauvel-Lafeve F, Bruel A, Vilar J, Bieche I, Laurendeau I, Galy-Fauroux I, Fischer AM, Boisson-Vidal C. Ex vivo priming of endothelial progenitor cells with SDF-1 before transplantation could increase their proangiogenic potential. Arterioscler Thromb Vasc Biol 28: 644-650, 2008.